ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 60 filers reported holding ACCELERON PHARMA INC in Q4 2013. The put-call ratio across all filers is - and the average weighting 1.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $31,536,000 | +33.3% | 183,241 | -2.8% | 0.02% | +36.4% |
| Q2 2021 | $23,651,000 | +41.7% | 188,472 | +53.2% | 0.01% | +22.2% |
| Q1 2021 | $16,689,000 | +34.9% | 123,060 | +27.2% | 0.01% | +12.5% |
| Q4 2020 | $12,375,000 | +13.7% | 96,723 | -0.0% | 0.01% | +14.3% |
| Q3 2020 | $10,886,000 | +3.6% | 96,745 | -12.2% | 0.01% | -12.5% |
| Q2 2020 | $10,504,000 | -15.2% | 110,242 | -20.0% | 0.01% | -27.3% |
| Q1 2020 | $12,389,000 | +95.4% | 137,856 | +15.3% | 0.01% | +175.0% |
| Q4 2019 | $6,340,000 | +37.3% | 119,591 | +2.2% | 0.00% | +33.3% |
| Q3 2019 | $4,619,000 | -11.4% | 116,969 | -7.9% | 0.00% | 0.0% |
| Q2 2019 | $5,213,000 | -4.6% | 126,987 | +8.1% | 0.00% | 0.0% |
| Q1 2019 | $5,467,000 | -20.2% | 117,465 | -25.3% | 0.00% | -40.0% |
| Q4 2018 | $6,850,000 | -80.8% | 157,347 | -74.8% | 0.01% | -50.0% |
| Q3 2018 | $35,718,000 | +23.3% | 624,167 | +4.5% | 0.01% | +25.0% |
| Q2 2018 | $28,968,000 | +40.0% | 597,101 | +12.8% | 0.01% | -20.0% |
| Q1 2018 | $20,697,000 | -8.7% | 529,419 | -0.9% | 0.01% | -33.3% |
| Q4 2017 | $22,671,000 | -34.4% | 534,257 | -42.3% | 0.02% | -37.5% |
| Q3 2017 | $34,556,000 | +192.3% | 925,992 | +137.9% | 0.02% | +200.0% |
| Q2 2017 | $11,824,000 | +29.1% | 389,162 | +12.5% | 0.01% | +14.3% |
| Q1 2017 | $9,156,000 | +27.3% | 345,936 | +22.7% | 0.01% | +16.7% |
| Q4 2016 | $7,192,000 | -37.7% | 281,887 | -11.6% | 0.01% | -25.0% |
| Q3 2016 | $11,543,000 | -9.0% | 319,033 | -14.5% | 0.01% | -11.1% |
| Q2 2016 | $12,680,000 | +54.7% | 373,247 | +20.2% | 0.01% | +50.0% |
| Q1 2016 | $8,195,000 | -0.0% | 310,622 | +84.7% | 0.01% | 0.0% |
| Q4 2015 | $8,198,000 | +221.1% | 168,175 | +63.9% | 0.01% | +200.0% |
| Q3 2015 | $2,553,000 | -29.9% | 102,595 | -10.9% | 0.00% | 0.0% |
| Q2 2015 | $3,641,000 | -1.8% | 115,116 | +18.1% | 0.00% | 0.0% |
| Q1 2015 | $3,709,000 | +9.9% | 97,485 | +12.5% | 0.00% | 0.0% |
| Q4 2014 | $3,374,000 | +17.7% | 86,661 | -8.6% | 0.00% | 0.0% |
| Q3 2014 | $2,866,000 | +43.2% | 94,841 | +60.9% | 0.00% | +100.0% |
| Q2 2014 | $2,001,000 | +1787.7% | 58,947 | +1805.2% | 0.00% | – |
| Q1 2014 | $106,000 | +10500.0% | 3,094 | +6775.6% | 0.00% | – |
| Q4 2013 | $1,000 | – | 45 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 1,449,300 | $59,537,000,000 | 6.61% |
| Foresite Capital Management II, LLC | 188,602 | $7,748,000 | 4.36% |
| Foresite Capital Management III, LLC | 254,923 | $10,472,000 | 3.43% |
| Artal Group S.A. | 1,500,000 | $61,620,000 | 2.49% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,305,174 | $53,617,000 | 1.93% |
| Asymmetry Capital Management, L.P. | 82,473 | $3,388,000 | 1.84% |
| QVT Financial LP | 190,977 | $7,845,000 | 1.66% |
| SECTORAL ASSET MANAGEMENT INC | 269,396 | $11,067,000 | 1.32% |
| Sofinnova Investments, Inc. | 241,043 | $9,902,000 | 0.91% |
| Novo Holdings A/S | 119,708 | $4,918,000 | 0.69% |